Close X
Friday, November 29, 2024
ADVT 
Health

Indian American Team Makes Gene-Editing Tool Simpler

IANS, 16 Jul, 2015 01:03 PM
    A team of Indian American researchers has developed a user-friendly resource to make the powerful gene-editing tool more friendly.
     
    The breakthrough has the potential to facilitate new discoveries in gene therapies and basic genetics research.
     
    The gene-editing technique called CRISPR/Cas9 has been widely adopted to make precise, targeted changes in DNA.
     
    The team describes an approach to simplify a labourious part of the gene editing process using the CRISPR/Cas9 system by choosing the best components to match specific gene targets.
     
    "We have taken a step towards making the CRISPR/Cas9 system more robust," said Prashant Mali, assistant professor (UC) Jacobs School of Engineering.
     
    CRISPR/Cas9 is a relatively new genome engineering tool that can target a particular segment of DNA in living cells -- such as a gene mutation -- and replace it with a genetic sequence.
     
    It has two components - a short "guide RNA" with a sequence matching a particular gene target, and a large protein called Cas9 that cuts DNA precisely at that target.
     
    "We built a computational model that accounts for all these different features. The end product is an interactive software for users to find guide RNAs that are predicted to be highly specific and highly active for their gene targets," said Raj Chari, research fellow from the department of genetics at the Harvard Medical School.
     
    This technology ultimately has applications in gene therapies for genetic disorders such as sickle cell anaemia and cystic fibrosis, said the paper published in the journal Nature Methods.
     
    "We hope to minimise the time and work in finding the most successful guide RNA sequence for a gene target, which will be helpful in finding new gene therapies," Chari said.
     
    The team believe this will be a useful resource for the community towards designing improved genome engineering experiments.

    MORE Health ARTICLES

    Living Kidney Donors Face Higher Health Risks During Later Pregnancies: Study

    Living Kidney Donors Face Higher Health Risks During Later Pregnancies: Study
    TORONTO — A new study says that women who have donated a kidney are at higher risk of developing gestational hypertension or a potentially dangerous condition called pre-eclampsia during pregnancies that follow the donation.

    Living Kidney Donors Face Higher Health Risks During Later Pregnancies: Study

    Over 400 cancer-causing 'hidden' faults detected in DNA

    Over 400 cancer-causing 'hidden' faults detected in DNA
    British scientists have discovered more than 400 "blind spots" in DNA which could hide cancer-causing gene faults....

    Over 400 cancer-causing 'hidden' faults detected in DNA

    Estrogen protects some women against heart disease

    Estrogen protects some women against heart disease
    Estrogens, also referred to as female sex hormones, have been thought to protect women from heart diseases and researchers have now found how they do so....

    Estrogen protects some women against heart disease

    How liver can improve diabetes management

    How liver can improve diabetes management
    Finding a way to stimulate glucose accumulation in the liver could help manage diabetes and obesity, shows a new research, paving the way for new...

    How liver can improve diabetes management

    Walnuts can slow down prostate cancer growth

    Walnuts can slow down prostate cancer growth
    “While they (walnuts) are high in fat, their fat does not drive prostate cancer growth. In fact, walnuts do just the opposite when fed to mice,” lead scientist and....

    Walnuts can slow down prostate cancer growth

    Tiny needles hold promise for two key eye diseases

    Tiny needles hold promise for two key eye diseases
    Needles too tiny to be seen with naked eyes can soon deliver drugs to specific areas relevant to two of the world's leading eye diseases - glaucoma and corneal....

    Tiny needles hold promise for two key eye diseases